According to IMARC Group latest report titled” Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the market grew at a CAGR of around 16% during 2014-2019. The global regenerative medicine market to exhibit moderate growth during the next five years.
Get a sample copy of this Report @ https://www.imarcgroup.com/regenerative-medicine-market/requestsample
Regenerative medicine refers to a field of biomedical sciences involved in restoring the structure and function of damaged cells, organs, and tissues. It includes the study of stem cells that are developed in laboratories and then safely inserted into the human body to regenerate damaged bones, cartilage, blood vessels, and organs. Cellular and acellular regenerative medicines are widely adopted in various clinical therapeutic procedures, including cell therapies, immunomodulation, and tissue engineering. They have the potential to treat various chronic diseases, including Alzheimer’s, Parkinson’s, cardiovascular disorders (CVDs), osteoporosis, spinal cord injuries, etc.
Get detailed information about market, click here @https://www.imarcgroup.com/regenerative-medicine-market
Market Trends and Driver:
The rising prevalence of chronic diseases and genetic disorders is primarily driving the demand for regenerative medicine across the globe. Moreover, the growing geriatric population who are more prone to musculoskeletal, dermatological, and cardiological disorders is also augmenting the need for regenerative medicines. Furthermore, several technological advancements in cell-based therapies have led to the adoption of 3D bioprinting techniques and artificial intelligence (AI), thereby further propelling the market for regenerative medicine. Moreover, regenerative medicine decreases the risk of organ rejection by the body post-transplant and increases the patient’s recovery speed, thereby gaining traction in numerous organ transplantation procedures. The increasing investments in extensive R&D activities in the field of medical sciences are expected to drive the market for regenerative medicine.
Keyplayers Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Allergan PLC (AbbVie Inc.), Amgen Inc., Baxter International Inc., BD (Becton, Dickinson and Company), Integra Lifesciences Holdings Corporation, Medtronic plc, Mimedx Group Inc., Novartis AG, Osiris Therapeutics Inc. (Smith & Nephew plc) and Thermo Fisher Scientific Inc.
Regenerative Medicine Market Segmentation:
Our report has categorized the market based on region, type, application and End-Use.
By Type:
- Stem Cell Therapy
- Biomaterial
- Tissue Engineering
- Others
By Application:
- Bone Graft Substitutes
- Osteoarticular Diseases
- Dermatology
- Cardiovascular
- Central Nervous System
- Others
By End User:
- Hospitals
- Specialty Clinics
- Others
By Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Note: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact US: IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
